ArticleAddiction neuroscience2026
Nicotine self-administration suppresses both pro- and anti-inflammatory accumbens cytokines but does not induce apoptosis in female rats.
Article in Addiction neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Nicotine can alter neuroimmune signaling within the brain reward pathway, and specifically, within the nucleus accumbens (NAc). Despite clinically meaningful sex differences in nicotine use as well as known sex differences in immune system function, no studies have evaluated NAc neuroimmune consequences following nicotine use in females. Thus, the present study evaluated cytokine expression and neuronal apoptosis in the ventral striatum (which encompasses the NAc) in ovary-intact female Long-Evans rats following nicotine or saline self-administration. Circulating cytokine levels were also evaluated in serum. Overall, pro-inflammatory cytokine levels were suppressed within the ventral striatum, with tumor necrosis factor-alpha (TNFα) being the most significantly suppressed. Interestingly, there was an increase in the chemokine fractalkine (FKN), a neuronal "help me" signal during distress. These results raise the possibility that chronic volitional nicotine use results in cleavage of FKN in response to neuronal distress, and glial cells may be unresponsive to these signals. In contrast, circulating serum cytokine levels remained mostly unchanged except for an increase in TNFα, suggesting that the immunosuppression observed following nicotine self-administration was largely localized to the brain. No measurable NAc apoptotic debris was identified, in line with our findings that interleukin-1β (IL-1β) was suppressed and raising the possibility that nicotine use suppresses NAc inflammasome activation. Thus, chronic nicotine use in female rats may disrupt ventral striatal neuroimmune homeostasis. Together, targeting nicotine-induced disruptions in neuroimmune homeostasis may represent novel therapeutic opportunities to mitigate the harmful effects of nicotine in females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.